w
TEST BANK FOR PHARMACOTHERAPEUTICS FOR ADVANCE
w w
w
w w
D PRACTICE A PRACTICAL APPROACH 5TH
w w w w w
EDITION BY VIRGINIA POOLE ARCANGELO; ANDREW
w w w w w
PETERSON; VERONICA WILBUR; JENNIFER A. REINHOLD
w w w w w w
PRINTED PDF I ORIGINAL DIRECTLY FROM THE PUBLISHER I 1OO%
w w w w w w w w w
VERIFIED ANSWERS ] DOWNLOAD IMMEDIATELY AFTER THE ORDER
w w w w w w w
['LIZ)LI12%5IL!
[LI.GIL
Complete Test bank, All Chapters are included.
w w w w w w
ForwmorewTestwbanks,wATI,wHES!wexams,wandwmorewcontactwus.
, Table of content
w w
Chapterw Iw IssueswforwthewPractitionerwinwDrugw Therapy
Chapterw2wPharmacokineticwBasiswofwTherapeuticswandwPharmacodynamicwPrinciples
wChapterw 3w Impactw ofwDrugwInteractionsw andw Adversew Eventsw onw Therapeutics w Cha
pterw4wPrincipleswofwPharmacotherapywinwPediatrics,wPregnancy,wandwLactationwCha
pterw5wPharmacotherapywPrincipleswinwOlderwAdults
Chapterw6wPrincipleswofwAntimicrobialwTherapywChapt
erw7wPharmacogenomies
Chapterw8wThewEconomicswofwPharmacotherapeuticsw
Chapterw9wPharmacotherapywofwPainwManagement
ChapterwI0wPainwManagementwinwOpioidwUsewDisorderw(OUD)wPatientsw
Chapterw11wCannabiswandwPainwManagement
Chapterw 12wContactwDermatitis
Chapterw13wFungal,wViral,wandwBacterialwInfectionswofwthewSkinw
Chapterw14wPsoriasis
ChapterwI5wAcnewVulgariswandwRosaceawChapt
erw16wOphthalmicwDisorders
ChapterwI7wOtitiswMediawandwOtitiswExternawC
hapterwI8wHypertension
Chapterw I9w Hyperlipidemia
Chapterw20wChronicwStablewAnginawandwMyocardialwInfarctionw
Chapterw2IwHeartwFailure
Chapterw22wArrhythmias
Chapterw23w RespiratorywInfections
Chapterw24wAsthmawandwChronicwObstructivewPulmonarywDiseasewChap
terw25wGastric,wFunctional,wandwInflammatorywBowelwDisorderswChapter
w26wGastroesophagealwRefluxwDiseasewandwPepticwUlcerwDiseasew Chapte
rw27wLiverwDiseases
Chapterw 28w UrinarywTractw Infection
Chapterw29wProstaticwDisorderswandwErectilewDysfunctionwChapt
erw30wOveractivewBladder
Chapterw3IwSexuallywTransmittedwInfection
swChapterw32wOsteoarthritiswandwGoutwCha
pterw33wOsteoporosis
Chapterw34wRheumatoidwArthritisw
Chapterw35wHeadaches
Chapterw36wSeizurewDisordersw
Chapterw37wAlzheimer'swDiseasew
Chapterw38w Parkinson'sw Diseas
e
Chapterw39wMajorwDepressivewDisorderwandwBipolarwDisordersw
Chapterw40wAnxietywDisorders
Chapterw 41w Sleepw Disorders
Chapterw42wAttentionwDeficitwHyperactivitywDisorderw
Chapterw43wSubstancewUsewDisorders
Chapterw44wDiabetesw Mellitus
Chapterw45w Thyroidw andw Parathyroidw Disorders
,Chapter 46 Allergies and Allergic Reactions
w w w w w
wChapter 47 Human Immunodeficiency Viru
w w w w
s Chapter 48 Organ Transplantation
w w w w
Chapter 49 Thromboembolic Disorders Ch
w w w w
apter 50 Anemias
w w
Chapter 5l Immunizations Cha
w w w
pter 52 Smoking Cessation Cha
w w w w
pter 53 Weight Loss Chapter 5
w w w w w
4 Contraception
w
Chapter 55 Menopausew w
Chapter 56 Vaginitisw w
, w
lOMoAR cPSD|
w 21007614
w w
lOMoAR cPSD| 21007614
Chapter 1 Issues for the Practitioner in Drug Therapy
w w w w w w w w
MULTIPLEwCHOICE
1. Nursewpractitionerwprescriptivewauthoritywiswregulatedwby:
A. ThewNationalwCouncilwofwStatewBoardswofwNursing
B. ThewU.S.wDrugwEnforcementwAdministration
C. ThewStatewBoardwofwNursingwforweachwstate
D. ThewStatewBoardwofwPharmacy
ANS:w C PTS:w 1
2. PhysicianwAssistantw(PA)wprescriptivewauthoritywiswregulatedwby:
A. ThewNationalwCouncilwofwStatewBoardswofwNursing
B. ThewU.S.wDrugwEnforcementwAdministration
C. ThewStatewBoardwofwNursing
D. ThewStatewBoardwofwMedicalwExaminers
ANS:w D PTS:w 1
3. Clinicalwjudgmentwinwprescribingwincludes:
A. Factoringwinwthewcostwtowthewpatientwofwthewmedicationwprescribed
B. Alwayswprescribingwthewnewestwmedicationwavailablewforwthewdiseasewprocess
C. Handingwoutwdrugwsampleswtowpoorwpatients
D. Prescribingwallwgenericwmedicationswtowcutwcosts
ANS:w A PTS:w 1
4. Criteriawforwchoosingwanweffectivewdrugwforwawdisorderwinclude:
A. Askingwthewpatientwwhatwdrugwtheywthinkwwouldwworkwbestwforwthem
B. Consultingwnationallywrecognizedwguidelineswforwdiseasewmanagement
C. Prescribingwmedicationswthatwarewavailablewaswsampleswbeforewwritingwawprescription
D. FollowingwU.S.wDrugwEnforcementwAdministrationw(DEA)wguidelineswfo
rwprescribing
ANS:w B PTS:w 1
5. Nursewpractitionerwpracticewmaywthrivewunderwhealth-carewreformwduewto:
A. Thewdemonstratedwabilitywofwnursewpractitionerswtowcontrolwcostswandwimprovewpatie
ntwoutcomes
B. Thewfactwthatwnursewpractitionerswwillwbewablewtowpracticewindependently
C. Thewfactwthatwnursewpractitionerswwillwhavewfullwreimbursementwunderwhealth-
carewreform
D. ThewabilitywtowshiftwaccountabilitywforwMedicaidwtowthewstatewlevel
ANS:w A PTS:w 1